|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01501 INT MEDICAL
Nominal 
26.500 -0.650 (-2.394%) Profitability Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| ROAA (%) | 8.948% | 8.113% | 7.638% | 9.392% | 8.919% |
| ROAE (%) | 11.212% | 9.898% | 9.060% | 10.585% | 9.624% |
| Return on Capital Employed (%) | 10.513% | 9.135% | 8.296% | 9.736% | 9.094% |
Margin Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Gross Profit Margin (%) | 63.109% | 58.189% | 56.750% | 59.341% | 65.401% |
| EBITDA Margin (%) | 33.683% | 28.432% | 28.838% | 37.018% | 37.677% |
| Pre-tax Profit Margin (%) | 25.046% | 23.262% | 24.658% | 33.505% | 38.246% |
| Net Profit Margin (%) | 22.526% | 20.782% | 22.481% | 30.766% | 33.857% |
Liquidity Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Current Ratio (X) | 2.053 X | 2.286 X | 3.346 X | 5.603 X | 11.868 X |
| Quick Ratio (X) | 1.680 X | 1.880 X | 2.702 X | 4.999 X | 11.243 X |
Leverage Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Total Liabilities / Total Assets(%) | 20.948% | 17.306% | 14.952% | 11.324% | 6.680% |
| Total Debt / Total Assets (%) | 10.783% | 4.670% | 2.672% | 0.827% | 0.122% |
| Net Debt / Total Assets (%) | -12.313% | -16.204% | -25.690% | -38.676% | -61.039% |
| Total Debt / Shareholders' Funds (%) | 13.735% | 5.747% | 3.229% | 0.961% | 0.133% |
| Long Term Debt / Shareholders' Funds (%) | 0.875% | 0.949% | 1.054% | 0.947% | 0.108% |
| Net Debt / Shareholders' Funds (%) | -15.684% | -19.942% | -31.047% | -44.941% | -66.511% |
| Net Cash / (Debt) ($) | 278.269M | 328.889M | 469.438M | 627.146M | 868.399M |
| Net Cash / (Debt) per share ($) | 1.581 | 1.923 | 2.794 | 3.778 | 5.231 |
| Total Debt / Capital Employed (%) | 13.349% | 5.534% | 3.075% | 0.913% | 0.130% |
| Interest Coverage Ratio (X) | 88.812 X | 55.830 X | 177.611 X | 246.957 X | 1491.054 X |
Efficiency Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Inventory Turnover (Day) | 169.038 Day | 164.109 Day | 177.728 Day | 142.673 Day | 145.141 Day |
| Receivables Turnover (Day) | 50.981 Day | 47.102 Day | 46.741 Day | 40.189 Day | 19.530 Day |
| Payables Turnover (Day) | 16.512 Day | 16.783 Day | 19.684 Day | 16.759 Day | 16.440 Day |
| Remarks: | Real time quote last updated: 30/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 191,914,000 |
| %Change | 22.662% |
| EPS / (LPS) | RMB 1.100 |
| NBV Per Share (¥) | RMB 10.081 |